Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Heart Failure Clinical Trial
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials
Heart Failure Clinical Trial
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Heart Failure Clinical Trial
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Toledo, OH
Click here to add this to my saved trials
Heart Failure Clinical Trial
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Valhalla, NY
Click here to add this to my saved trials
Heart Failure Clinical Trial
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Washington DC,
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling, Phase II
Updated: 2/28/2016
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling, Phase II
Updated: 2/28/2016
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling, Phase II
Updated: 2/28/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling, Phase II
Updated: 2/28/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling, Phase II
Updated: 2/28/2016
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Virus (HCV) Genotype (GT) 3, GT4, GT5, and GT6 Infection (MK-3682-012)
Status: Enrolling, Phase II
Updated: 6/28/2016
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Virus (HCV) Genotype (GT) 3, GT4, GT5, and GT6 Infection (MK-3682-012)
Status: Enrolling, Phase II
Updated: 6/28/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164)
Status: Enrolling, Phase II
Updated: 6/28/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164)
Status: Enrolling, Phase II
Updated: 6/28/2016
Merck Sharp & Dohme
mi
from
North Ryde,
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164)
Status: Enrolling, Phase II
Updated: 6/28/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Muscle Invasive Bladder Cancer Clinical Trial
Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Muscle Invasive Bladder Cancer Clinical Trial
Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)
Status: Enrolling, Phase II
Updated: 12/31/1969
Southeastern Medical Oncology Center
mi
from
Jacksonville, NC
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)
Status: Enrolling, Phase II
Updated: 12/31/1969
Sanford Gynecologic Oncology Clinic
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Concord Repatriation General Hospital
mi
from
Concord,
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Strong Health System
mi
from
Rochester, NY
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
Bedford, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
Buffalo, NY
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
Fullerton, CA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
Goshen, IN
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
La Crosse, WI
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Merck Sharp & Dohme
mi
from
North Ryde,
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
Paramus, NJ
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
Roanoke, VA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
VA Comprehensive Cancer Center
mi
from
West Haven, CT
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling, Phase I
Updated: 12/14/2017
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction
Status: Enrolling, Phase II
Updated: 2/2/2018
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction
Status: Enrolling, Phase II
Updated: 2/2/2018
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction
Status: Enrolling, Phase II
Updated: 2/2/2018
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction
Status: Enrolling, Phase II
Updated: 2/2/2018
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction
Status: Enrolling, Phase II
Updated: 2/2/2018
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Pulmonary / Respiratory Diseases Clinical Trial
TandemHeart Experiences and MEthods (THEME Registry)
Status: Enrolling, Phase
Updated: 12/31/1969
Princeton Baptist Medical Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling, Phase III
Updated: 12/7/2016
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling, Phase III
Updated: 12/7/2016
Clinical Research Facility
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling, Phase III
Updated: 12/7/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling, Phase III
Updated: 12/7/2016
Clinical Research Facility
mi
from
Easton, PA
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling, Phase III
Updated: 12/7/2016
Clinical Research Facility
mi
from
Fairfax, VA
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling, Phase III
Updated: 12/7/2016
Clinical Research Facility
mi
from
Farmington, CT
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling, Phase III
Updated: 12/7/2016
Clinical Research Facility
mi
from
Hollywood, FL
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling, Phase III
Updated: 12/7/2016
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling, Phase III
Updated: 12/7/2016
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling, Phase III
Updated: 12/7/2016
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling, Phase III
Updated: 12/7/2016
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling, Phase III
Updated: 12/7/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling, Phase III
Updated: 12/7/2016
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling, Phase III
Updated: 12/7/2016
Clinical Research Facility
mi
from
Tyler, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Smilow Cancer Center at Yale New Haven Hospital, oncology Pharmacy
mi
from
New Haven, CT
Click here to add this to my saved trials
Gout Clinical Trial
DECT Study in Allopurinol-Treated Gout Patients
Status: Enrolling
Updated: 1/26/2016
mi
from
Vancouver,
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling, Phase II
Updated: 1/21/2016
Clinical Research Facility
mi
from
Hershey, PA
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling, Phase II
Updated: 1/21/2016
Clinical Research Facility
mi
from
High Point, NC
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling, Phase II
Updated: 1/21/2016
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Epilepsy Clinical Trial
A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications
Status: Enrolling, Phase III
Updated: 12/31/1969
Sp0982 053
mi
from
Austin, TX
Click here to add this to my saved trials
Epilepsy Clinical Trial
A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications
Status: Enrolling, Phase III
Updated: 12/31/1969
Sp0982 013
mi
from
Panama City, FL
Click here to add this to my saved trials
Carotid Atherosclerosis Clinical Trial
PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis
Status: Enrolling, Phase I
Updated: 12/31/1969
Washington University in St.Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Sapanisertib in Treating Patients With Stage IV or Recurrent Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Monmouth
mi
from
Middletown, NJ
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase II
Updated: 2/26/2016
Clinical Research Facility
mi
from
Augusta, GA
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase II
Updated: 2/26/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase II
Updated: 2/26/2016
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase II
Updated: 2/26/2016
Clinical Research Facility
mi
from
Florissant, MO
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase II
Updated: 2/26/2016
Clinical Research Facility
mi
from
Irvine, CA
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase II
Updated: 2/26/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase II
Updated: 2/26/2016
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase II
Updated: 2/26/2016
Clinical Research Facility
mi
from
Southfield, MI
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase II
Updated: 2/26/2016
Clinical Research Facility
mi
from
Springfield, IL
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase II
Updated: 2/26/2016
Clinical Research Facility
mi
from
Towson, MD
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase II
Updated: 2/26/2016
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic Fibrosis
Status: Enrolling
Updated: 1/26/2018
CFF Pediatric Program University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic Fibrosis
Status: Enrolling
Updated: 1/26/2018
CFF Pediatric Program, University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic Fibrosis
Status: Enrolling
Updated: 1/26/2018
CFF Adult Program, University of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Locally Recurrent/Metastatic Triple Negative Breast Cancer Clinical Trial
Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Locally Recurrent/Metastatic Triple Negative Breast Cancer Clinical Trial
Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Nassau
mi
from
Uniondale, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
Status: Enrolling, Phase II
Updated: 12/31/1969
Siteman Cancer Center- Washington University School of Medicine in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)
Status: Enrolling, Phase I
Updated: 12/31/1969
Beth Israel Deaconess Med Ctr; Hem/Onc
mi
from
Boston, MA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)
Status: Enrolling, Phase I
Updated: 12/31/1969
UT Southwestern MC at Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder
Status: Enrolling, Phase III
Updated: 12/31/1969
Eastside Therapeutic Resource dba Core Clinical
mi
from
Everett, WA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder
Status: Enrolling, Phase III
Updated: 12/31/1969
Kolade Research Institute
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder
Status: Enrolling, Phase III
Updated: 12/31/1969
CITrials - Riverside
mi
from
Riverside, CA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder
Status: Enrolling, Phase III
Updated: 12/31/1969
Institue for Behavioral Medicine
mi
from
Smyrna, GA
Click here to add this to my saved trials
Lymphangioleiomyomatosis Clinical Trial
Safety and Durability of Sirolimus for Treatment of LAM
Status: Enrolling, Phase
Updated: 4/10/2018
Loyola University Medical Center, Chicago
mi
from
Maywood, IL
Click here to add this to my saved trials
Scoliosis Clinical Trial
Prospective Multicenter Evaluation of a New Predictive Model for the Progression of Adolescent Idiopathic Scoliosis
Status: Enrolling, Phase
Updated: 12/31/1969
St Justine's Hospital
mi
from
Montreal,
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Respiratory Motion-Corrected Cone-Beam CT and Intratreatment Gating Based on Electromagnetic Transponders to Reduce Target Position Uncertainty in Radiation Treatment of Lung Malignancies
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Hepatocellular Carcinoma Clinical Trial
A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein
Status: Enrolling, Phase III
Updated: 12/31/1969
Pacific Hematology and Oncology Associates
mi
from
Daly City, CA
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Physician Initiated Expanded Access Request for Migalastat in Individual Patients With Fabry Disease
Status: Enrolling, Phase
Updated: 12/31/1969
The Royal Melbourne Hospital
mi
from
Parkville,
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Chicago, Investigational Drug Service Pharmacy
mi
from
Chicago, IL
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Norton Children´s Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
UC Davis Medical Center Main Hospital
mi
from
Sacramento, CA
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Children's Hematology and Oncology Associates,P.A.
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Lumbar Degenerative Disc Disease Clinical Trial
Spineology Clinical Outcomes Trial: An IDE Investigation
Status: Enrolling
Updated: 11/29/2016
Bronson Healthcare Methodist Hospital - Neuroscience Center
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects
Status: Enrolling, Phase I, II
Updated: 2/7/2018
Community Regional Cancer Care
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects
Status: Enrolling, Phase I, II
Updated: 2/7/2018
IU Health Central Indiana Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects
Status: Enrolling, Phase I, II
Updated: 2/7/2018
Washington University: Siteman Cancer Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling, Phase III
Updated: 12/31/1969
Asheville Gastroenterology Associates, P.A.; Gastroenterology
mi
from
Asheville, NC
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Digestive Disease Consultants - Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials